A detailed history of Black Rock Inc. transactions in Annexon, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 6,587,287 shares of ANNX stock, worth $36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,587,287
Previous 5,043,530 30.61%
Holding current value
$36 Million
Previous $36.2 Million 10.74%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$4.33 - $6.79 $6.68 Million - $10.5 Million
1,543,757 Added 30.61%
6,587,287 $32.3 Million
Q1 2024

May 10, 2024

BUY
$4.03 - $7.81 $6.95 Million - $13.5 Million
1,724,951 Added 51.98%
5,043,530 $36.2 Million
Q4 2023

Feb 13, 2024

SELL
$1.63 - $4.63 $145,738 - $413,968
-89,410 Reduced 2.62%
3,318,579 $15.1 Million
Q3 2023

Nov 13, 2023

SELL
$2.13 - $3.84 $153,161 - $276,122
-71,907 Reduced 2.07%
3,407,989 $8.04 Million
Q2 2023

Aug 11, 2023

BUY
$2.1 - $6.37 $4.87 Million - $14.8 Million
2,318,780 Added 199.7%
3,479,896 $12.2 Million
Q1 2023

May 12, 2023

BUY
$3.74 - $7.46 $3,141 - $6,266
840 Added 0.07%
1,161,116 $4.47 Million
Q4 2022

Feb 13, 2023

BUY
$4.56 - $6.61 $90,415 - $131,063
19,828 Added 1.74%
1,160,276 $6 Million
Q3 2022

Nov 14, 2022

BUY
$3.75 - $6.63 $672,768 - $1.19 Million
179,405 Added 18.67%
1,140,448 $7.05 Million
Q2 2022

Aug 12, 2022

SELL
$2.11 - $4.06 $3.39 Million - $6.53 Million
-1,608,854 Reduced 62.6%
961,043 $3.62 Million
Q1 2022

May 12, 2022

SELL
$2.73 - $11.94 $122,014 - $533,646
-44,694 Reduced 1.71%
2,569,897 $7.02 Million
Q4 2021

Feb 10, 2022

SELL
$11.49 - $22.0 $3.04 Million - $5.81 Million
-264,283 Reduced 9.18%
2,614,591 $30 Million
Q3 2021

Nov 09, 2021

SELL
$16.35 - $23.4 $4.2 Million - $6.01 Million
-256,944 Reduced 8.19%
2,878,874 $53.6 Million
Q2 2021

Aug 11, 2021

BUY
$17.81 - $27.48 $55.8 Million - $86.2 Million
3,135,818 New
3,135,818 $70.6 Million

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $260M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.